Targeting Ca 2+ channels to treat pain: T-type versus N-type

Trends in Pharmacological Sciences

Volumn 25, Issue 9, 2004, Pages 465-470

  Altier, Christophe ^a   Zamponi, Gerald W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZOXYANILINE; ANALGESIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL T TYPE; GABAPENTIN; MORPHINE; OMEGA CONOTOXIN CVID; OMEGA CONOTOXIN MVIIA; UNCLASSIFIED DRUG; PROTEIN SUBUNIT;

ADDICTION; ANALGESIA; BEHAVIOR DISORDER; CHRONIC PAIN; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; HUMAN; HYPOTENSION; MIGRAINE; NEUROPATHIC PAIN; PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; TRIGEMINUS NEURALGIA; ANIMAL; CALCIUM SIGNALING; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY;

ANALGESICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CALCIUM CHANNELS, T-TYPE; CALCIUM SIGNALING; HUMANS; PAIN; PROTEIN SUBUNITS;

EID: 4344661569     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.07.004     Document Type: Review

References (61)

1. P.A. Smith Neuropathic pain: drug targets for current and future interventions Drug News Perspect. 17 2004 5 17
2. P.A. Smith Neuropathic pain and the electrophysiology and pharmacology of nerve injury Drug Dev. Res. 54 2001 140 153
3. F. Porreca Chronic pain and medullary descending facilitation Trends Neurosci. 25 2002 319 325
4. G.W. Zamponi, and C.R. Triggle Pain control: what a pain! Drug Dev. Res. 54 2001 117
5. C. Krarup An update on electrophysiological studies in neuropathy Curr. Opin. Neurol. 16 2003 603 612
6. J. Scholz, and C.J. Woolf Can we conquer pain? Nat. Neurosci. 5 Suppl. 2002 1062 1067
7. D. Julius, and A.I. Basbaum Molecular mechanisms of nociception Nature 413 2001 203 210
8. C.J. Woolf, and M.W. Salter Neuronal plasticity: increasing the gain in pain Science 288 2000 1765 1769
9. M.T. Smith The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices Pain 96 2002 119 127
10. 2+ channel EMBO J. 20 2001 2349 2356
11. 2+ channels NeuroReport 12 2001 2423 2427
12. T.J. Bell Cell-specific alternative splicing increases calcium channel current density in the pain pathway Neuron 41 2004 127 138
13. A.M. Beedle Agonist-independent modulation of N-type calcium channels by ORL1 receptors Nat. Neurosci. 7 2004 118 125
14. C. Gouarderes Nociceptin receptors in the rat spinal cord during morphine tolerance Brain Res. 838 1999 85 94
15. G. Vanegas Side effects of morphine administration in cancer patients Cancer Nurs. 21 1998 289 297
16. D.A. Scott Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat Eur. J. Pharmacol. 451 2002 279 286
17. P.S. Staats Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial J. Am. Med. Assoc. 291 2004 63 70
18. R.D. Penn, and J.A. Paice Adverse effects associated with the intrathecal administration of ziconotide Pain 85 2000 291 296
19. Z.P. Feng Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA J. Biol. Chem. 278 2003 20171 20178
20. D.J. Adams Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals J. Biol. Chem. 278 2003 4057 4062
21. L.Y. Hu Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers Bioorg. Med. Chem. Lett. 9 1999 1121 1126
22. T. Seko L-Cysteine based N-type calcium channel blockers: structure-activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models Bioorg. Med. Chem. Lett. 12 2002 2267 2269
23. M.S. Gold Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro J. Neurosci. 18 1998 10345 10355
24. H. Khosravani Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy J. Biol. Chem. 279 2004 9681 9684
25. M.C. Nowycky Three types of neuronal calcium channel with different calcium agonist sensitivity Nature 316 1985 440 443
26. E. Carbone, and H.D. Lux A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones Nature 310 1984 501 502
27. J.L. Bossu Depolarization elicits two distinct calcium currents in vertebrate sensory neurones Pflugers Arch. 403 1985 360 368
28. E.M. Talley Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels J. Neurosci. 19 1999 1895 1911
29. J.B. Shin A T-type calcium channel required for normal function of a mammalian mechanoreceptor Nat. Neurosci. 6 2003 724 730
30. P.D. Ryu, and M. Randic Low- and high-voltage-activated calcium currents in rat spinal dorsal horn neurons J. Neurophysiol. 63 1990 273 285
31. H. Ikeda Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia Science 299 2003 1237 1240
32. A. Dogrul Reversal of experimental neuropathic pain by T-type calcium channel blockers Pain 105 2003 159 168
33. S.J. Flatters, and G.J. Bennett Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy Pain 109 2004 150 161
34. S.M. Todorovic Redox modulation of T-type calcium channels in rat peripheral nociceptors Neuron 31 2001 75 85
35. 2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia Pain 109 2004 328 339
36. S.M. Todorovic Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker Brain Res. 951 2002 336 340
37. Bourinet, E. et al. (2004) European Winter Brain Research Conference Abstracts
38. 2+ channels Science 302 2003 117 119
39. B. Nicholson Gabapentin use in neuropathic pain syndromes Acta Neurol. Scand. 101 2000 359 371
40. M. Shimoyama Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn Pain 85 2000 405 414
41. 2+ channels via GABAB receptors in hippocampal pyramidal cells Synapse 50 2003 95 109
42. D.J. Martin Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression Neuropharmacology 42 2002 353 366
43. 2+ influx into cultured rat dorsal root ganglion neurons and F11 neuroblastoma cells J. Physiol. 528 2000 70P
44. K.G. Sutton Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones Br. J. Pharmacol. 135 2002 257 265
45. N.S. Gee The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel J. Biol. Chem. 271 1996 5768 5776
46. Z.D. Luo Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin J. Pharmacol. Exp. Ther. 303 2002 1199 1205
47. S.J. Dubel Plasma membrane expression of T-type calcium channel alpha 1 subunits is modulated by HVA auxiliary subunits J. Biol. Chem. 279 2004 29263 29269
48. 2+ channels by gabapentin FEBS Lett. 528 2002 177 182
49. G.W. Zamponi Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha1 subunit Nature 385 1997 442 446
50. 2+ channels Annu. Rev. Cell Dev. Biol. 16 2000 521 555
51. P.A. Wielowieyski Alternative splicing in intracellular loop connecting domains II and III of the alpha 1 subunit of Cav1.2 Ca2+ channels predicts two-domain polypeptides with unique C-terminal tails J. Biol. Chem. 276 2001 1398 1406
52. E. Bourinet Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels Nat. Neurosci. 2 1999 407 415
53. K. Deisseroth Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity Neuron 16 1996 89 101
54. K. Deisseroth Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons Nature 392 1998 198 202
55. R.E. Dolmetsch Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway Science 294 2001 333 339
56. A.M. Yunker, and M.W. McEnery Low-voltage-activated ("T-Type") calcium channels in review J. Bioenerg. Biomembr. 35 2003 533 575
57. S.W. Hughes Cellular mechanisms of the slow (<1 Hz) oscillation in thalamocortical neurons in vitro Neuron 33 2002 947 958
58. A. Maximov, and I. Bezprozvanny Synaptic targeting of N-type calcium channels in hippocampal neurons J. Neurosci. 22 2002 6939 6952
59. S. Herlitze Targeting mechanisms of high voltage-activated Ca2+ channels J. Bioenerg. Biomembr. 35 2003 621 637
60. 2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex Trends Pharmacol. Sci. 22 2001 519 525
61. N. Klugbauer Calcium channel alpha2delta subunits: differential expression, function, and drug binding J. Bioenerg. Biomembr. 35 2003 639 647